On February 28 2020 Jean-Eric Paquet (Director-General of the Research and Innovation department) wrote the following on Twitter:
”Rare diseases are a priority area of research funding for the EU. This is why we will continue to invest in R&I through #HorizonEU to further increase the concrete impact on #rarediseases.”
Together with this post he attached the Factsheet: Showcasing development of therapies for rare diseases. The AML-VACCiN project has been highlight on page 1.
You’ll find the factsheet by clicking on this link: Promotion AML-VACCiN by the EU